FITB vs VRTX · P/E 17, rev $3.37B vs P/E 30, rev $3.33B
Fifth Third Bancorp (FITB) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
Fifth Third Bancorp (FITB) is a banks - regional company listed on US.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported FITB revenue for 2026-06-30 was $3.37B. Net income was $801.0M. Revenue was up 13.5% from 2026-03-31 to 2026-06-30. FITB currently screens at market cap $45.25B and trailing P/E 16.8.
Latest reported VRTX revenue for 2026-06-30 was $3.33B. Net income was $1.10B. Revenue was up 11.6% from 2026-03-31 to 2026-06-30. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
FITB currently screens at market cap $45.25B and trailing P/E 16.8. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the FITB and VRTX stock pages for the full models.
Not investment advice.